Search Within

Daniel Hirschhorn Cymerman

  1. "MSK Grad Students"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (8)
  2. GSK Faculty (8)
  3. MSK Grad Students (8)
  4. Melanoma and Immunotherapeutics Service (8)
  5. Sloan Kettering Institute Postdocs (8)
  6. Solid Tumor Oncology Division (8)

More Groups

People
  1. Jedd Wolchok (8)
  2. Taha Merghoub (8)
  3. Sadna Budhu (7)
  4. Sara Schad (6)
  5. Andrew Chow (4)
  6. Levi Mark Mangarin (4)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (2)
  5. 2019 (1)
  6. 2018 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (2)
  2. Cancer Research (1)
  3. Cell Reports (1)
  4. Immunity (1)
  5. Journal of Clinical Investigation (1)
  6. Journal of Experimental Medicine (1)

More Publications

Publishers
  1. Biomed Central Ltd (2)
  2. Cell Press (2)
  3. American Association for Cancer Research (1)
  4. American Society for Clinical Investigation (1)
  5. Rockefeller University Press (1)
  6. The American Association of Immunologists, Inc (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
    Journal Article

    Schad, S. E.; Chow, A.; Mangarin, L.; Pan, H.; Zhang, J.; Ceglia, N.; Caushi, J. X.; Malandro, N.; Zappasodi, R.; Gigoux, M.; more...
    Journal of Experimental Medicine (2022)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Targeting phosphatidylserine enhances the anti-tumor response to tumor-directed radiation therapy in a preclinical model of melanoma
    Journal Article

    Budhu, S.; Giese, R.; Gupta, A.; Fitzgerald, K.; Zappasodi, R.; Schad, S.; Hirschhorn, D.; Campesato, L. F.; De Henau, O.; Gigoux, M.; more...
    Cell Reports (2021)

    Fulltext@MSK | Save
  • Characterizing double positive T cells in the tumor microenvironment: A tale of promiscuous cell fates
    Meeting Abstract

    Schad, S.; Chow, A.; Pan, H.; Mangarin, L.; Zappasodi, R.; Gigoux, M.; Redmond, D.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody enhances anti-tumor activity of adoptive cell therapies in a mouse melanoma model
    Meeting Abstract

    Schad, S.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; Yang, X.; Merghoub, T.; Wolchok, J. D.
    Journal of Immunology (2020)

    Fulltext@MSK | Save
  • In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
    Journal Article

    Khalil, D. N.; Suek, N.; Campesato, L. F.; Budhu, S.; Redmond, D.; Samstein, R. M.; Krishna, C.; Panageas, K. S.; Capanu, M.; Houghton, S.; more...
    Journal of Clinical Investigation (2019)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody enhances antitumor activity of CAR T cells in mouse melanoma
    Meeting Abstract

    Schad, S.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; Yang, X.; Shan, J.; King, S.; Merghoub, T.; Wolchok, J.
    Cancer Research (2018)

    Fulltext@MSK | Save